T
51
-2
F
48
-3
WYNN
42
4
NVDA
54
2
PGR
67
2
BBY
40
-3
CAG
36
2
NWS
60
2
CMG
69
-3
MTCH
55
2
DG
29
19
LH
46
-2
NI
75
-2
XRX
44
2
AKAM
53
2
PHM
64
-2
BXP
55
-4
PNW
67
-3
FOX
64
14
AVB
65
-2
T
51
-2
F
48
-3
WYNN
42
4
NVDA
54
2
PGR
67
2
BBY
40
-3
CAG
36
2
NWS
60
2
CMG
69
-3
MTCH
55
2
DG
29
19
LH
46
-2
NI
75
-2
XRX
44
2
AKAM
53
2
PHM
64
-2
BXP
55
-4
PNW
67
-3
FOX
64
14
AVB
65
-2
Financhill
Back

BNY Mellon Emerging Markets Equity ETF Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
54

BKEM
BNY Mellon Emerging Markets Equity ETF

Last Price:
59.71
Seasonality Move:
3.52%
Sell
25

DRUG
Bright Minds Biosciences

Last Price:
43.34
Seasonality Move:
-15.89%
Buy
54
BNY Mellon Emerging Markets Equity ETF (BKEM) is a Buy

Is BNY Mellon Emerging Markets Equity ETF a Buy, Sell or Hold?

  • The current BNY Mellon Emerging Markets Equity ETF [BKEM] share price is $60.09. The Score for BKEM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BKEM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKEM Stock Price Chart

What is BNY Mellon Emerging Markets Equity ETF's stock price today?

  • The BNY Mellon Emerging Markets Equity ETF share price today is $60.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BKEM is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $44.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

BKEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 41.87 Sell
Chaikin Money Flow: 1635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.84 - 62.02) Sell
Bollinger Bands (100): (59.06 - 62.98) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.5 Buy
Relative Strength Index (14 RSI): 58.93 Buy
Chaikin Money Flow: 115403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.12 - 49.42) Buy
Bollinger Bands (100): (-5.11 - 34.85) Buy

BKEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.13 Sell
20-day SMA: 60.66 Sell
50-day SMA: 62.29 Sell
200-day SMA: 59.64 Buy
8-day EMA: 60.12 Sell
20-day EMA: 60.63 Sell
50-day EMA: 61.23 Sell
200-day EMA: 59.69 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.17 Buy
20-day SMA: 42.3 Buy
50-day SMA: 28.61 Buy
200-day SMA: 8.06 Buy
8-day EMA: 39.27 Buy
20-day EMA: 39.13 Buy
50-day EMA: 31.07 Buy
200-day EMA: 12.97 Buy

BNY Mellon Emerging Markets Equity ETF Earnings Growth & BKEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BNY Mellon Emerging Markets Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):